Risk Factors, Prognosis, and a New Nomogram for Predicting Cancer-Specific Survival Among Lung Cancer Patients with Brain Metastasis: A Retrospective Study Based on SEER

Overview

Journal Lung

Specialty Pulmonary Medicine

Date 2022 Jan 24

PMID 35067758

Authors

Gui Hong Zhang

Yue Jiao Liu

Ming De Ji

Affiliations

Soon will be listed here.

Abstract

Purpose: To make a comprehensive population-based study on risk and prognostic factors of brain metastasis from lung cancer.

Methods: A total of 91,643 patients diagnosed with lung cancer from 2010 to 2018 were collected from the Surveillance, Epidemiology and End results (SEER) database. To analyze the risk and prognostic factors of brain metastasis among lung cancer patients, both Logistic and Cox regression methods were applied, respectively. Also, the competing risk regression model was performed to establish a new nomogram to predict cancer-specific survival (CSS).

Results: Among the 91,643 lung cancer patients, 10,855 were found to have brain metastasis, with the incidence of 11.84%. The residence, age, race, income, primary site, histological type, extracranial metastasis, T stage, and N stage were all found to be independent risk factors of brain metastasis. The median overall survival (OS) of brain metastasis patients was limited to 6.08 months. By dividing patients randomly into a primary cohort with 7237 patients and a validation cohort with 3618 patients, a conclusion that the income, race, gender, age, histological type, extracranial metastasis, T stage, and N stage were all associated with the prognosis of brain metastasis was drawn. Our established primary-cohort-based new nomogram showed a good discriminative ability in predicting the probability of CSS among patients with brain metastasis, and the C-index was 0.62. Besides, the calibration curves for CSS also showed that the predicted survival by nomogram was consistent with the actual survival in the validation cohort.

Conclusion: Our study shall provide a deeper insight into the risk factors and prognosis of brain metastasis among lung cancer patients.

Citing Articles

Evolving prognostic paradigms in lung adenocarcinoma with brain metastases: a web-based predictive model enhanced by machine learning.

Liang M, Zhang Z, Wu L, Chen M, Tan S, Huang J Discov Oncol. 2025; 16(1):117.

PMID: 39904937 PMC: 11794753. DOI: 10.1007/s12672-025-01854-3.

Machine learning-based prognostic models and factors influencing the benefit of surgery on primary lesion for patients with lung cancer brain metastases.

Zhao X, Li C, Liu M, Feng Z, Wei X, Wang Y Am J Cancer Res. 2024; 14(11):5154-5177.

PMID: 39659929 PMC: 11626286. DOI: 10.62347/PRFQ9244.

Machine learning-based prediction model for brain metastasis in patients with extensive-stage small cell lung cancer.

Munai E, Zeng S, Yuan Z, Yang D, Jiang Y, Wang Q Sci Rep. 2024; 14(1):28790.

PMID: 39567766 PMC: 11579493. DOI: 10.1038/s41598-024-80425-y.

Application of random survival forest to establish a nomogram combining clinlabomics-score and clinical data for predicting brain metastasis in primary lung cancer.

Shi Z, Chen Y, Liu A, Zeng J, Xie W, Lin X Clin Transl Oncol. 2024; .

PMID: 39225959 DOI: 10.1007/s12094-024-03688-x.

Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database.

Zhang J, Zhang J BMC Pulm Med. 2023; 23(1):413.

PMID: 37899470 PMC: 10614355. DOI: 10.1186/s12890-023-02722-y.

References

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Wang X, Adjei A . Lung cancer and metastasis: new opportunities and challenges. Cancer Metastasis Rev. 2015; 34(2):169-71. DOI: 10.1007/s10555-015-9562-4. View

Goldberg S, Contessa J, Omay S, Chiang V . Lung Cancer Brain Metastases. Cancer J. 2015; 21(5):398-403. DOI: 10.1097/PPO.0000000000000146. View

Ji Z, Bi N, Wang J, Hui Z, Xiao Z, Feng Q . Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation. Int J Radiat Oncol Biol Phys. 2014; 89(2):330-7. DOI: 10.1016/j.ijrobp.2014.02.025. View

An N, Jing W, Wang H, Li J, Liu Y, Yu J . Risk factors for brain metastases in patients with non-small-cell lung cancer. Cancer Med. 2018; 7(12):6357-6364. PMC: 6308070. DOI: 10.1002/cam4.1865. View

Sperduto P, Yang T, Beal K, Pan H, Brown P, Bangdiwala A . Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2016; 3(6):827-831. PMC: 5824323. DOI: 10.1001/jamaoncol.2016.3834. View

Wang M, Wu Q, Zhang J, Qin G, Yang T, Liu Y . Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database. Cancer Med. 2020; 10(2):471-482. PMC: 7877345. DOI: 10.1002/cam4.3562. View

Martin A, Cagney D, Catalano P, Warren L, R Bellon J, Punglia R . Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol. 2017; 3(8):1069-1077. PMC: 5824221. DOI: 10.1001/jamaoncol.2017.0001. View

Ruiz-Cerda J, Soto-Poveda A, Lujan-Marco S, Loras-Monfort A, Trassierra-Villa M, Rogel-Berto R . Competing risk analysis of mortality in prostate cancer treated with radical prostatectomy. Actas Urol Esp. 2016; 41(1):11-22. DOI: 10.1016/j.acuro.2016.02.004. View

10.

Pugh T, Gaspar L . Prophylactic cranial irradiation for patients with lung cancer. Clin Lung Cancer. 2007; 8(6):365-8. DOI: 10.3816/CLC.2007.n.016. View

11.

Kilickap S, Aksoy S, Erman M . Multivariate analysis of factors predictive of brain metastases in localised non-small call lung carcinoma. Lung Cancer. 2005; 49(1):129. DOI: 10.1016/j.lungcan.2004.12.014. View

12.

Robnett T, Machtay M, Stevenson J, Algazy K, Hahn S . Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol. 2001; 19(5):1344-9. DOI: 10.1200/JCO.2001.19.5.1344. View

13.

Sun D, Hu L, Cai Y, Li X, Ye L, Hou H . A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer. Asian Pac J Cancer Prev. 2014; 15(3):1233-9. DOI: 10.7314/apjcp.2014.15.3.1233. View

14.

Jacot W, Quantin X, Boher J, Andre F, Moreau L, Gainet M . Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer. 2001; 84(7):903-9. PMC: 2363840. DOI: 10.1054/bjoc.2000.1706. View

15.

Ceresoli G, Reni M, Chiesa G, Carretta A, Schipani S, Passoni P . Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer. 2002; 95(3):605-12. DOI: 10.1002/cncr.10687. View

16.

Schouten L, Rutten J, Huveneers H, Twijnstra A . Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002; 94(10):2698-705. DOI: 10.1002/cncr.10541. View

17.

Ali A, Goffin J, Arnold A, Ellis P . Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases. Curr Oncol. 2013; 20(4):e300-6. PMC: 3728058. DOI: 10.3747/co.20.1481. View

18.

Cagney D, Martin A, Catalano P, Redig A, Lin N, Lee E . Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017; 19(11):1511-1521. PMC: 5737512. DOI: 10.1093/neuonc/nox077. View